Michael C. Van Zandt

Medical Discovery Partners (United States)

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “OST Catalytic Subunit Redundancy Enables Therapeutic Targeting of N-Glycosylation”.

OST Catalytic Subunit Redundancy Enables Therapeutic Targeting of N-Glycosylation

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.03.626593

N/A

0DataRank · unranked

0 citations

Hojin Lee, Vanessa Kelley, Rongliang Lou, Chatchai Phoomak, Katerina Politi +4 more

Redundancy of the OST catalytic subunit facilitates therapeutic targeting of N-glycosylation

Cell chemical biology(2025)10.1016/j.chembiol.2025.05.005

N/A

0DataRank · unranked

7 citations

Hojin Lee, Vanessa Kelley, Rongliang Lou, Chatchai Phoomak, Katerina Politi +4 more

Novel Quinazoline Derivatives Inhibit Splicing of Fungal Group II Introns

ACS Chemical Biology(2025)10.1021/acschembio.4c00631

N/A

0DataRank · unranked

4 citations

M.‐Z. LUO, G. Erik Jagdmann, Michael C. Van Zandt, Luke J. Sisto, Anna Marie Pyle +1 more

Molecular insights into de novo small-molecule recognition by an intron RNA structure

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2502425122

N/A

0DataRank · unranked

4 citations

Ling Xu, Kevin Chung, Luke J. Sisto, Jimin Hwang, Chengxin Zhang +3 more